TIANAN MEDICARE (00383) released its interim results, with profit attributable to shareholders reaching 47.361 million Hong Kong dollars, an increase of 295.37% year-on-year.

TIANAN MEDICARE (00383) announced its interim results for the six months ending June 30, 2026, reporting revenue of HKD 827 million, a year-on-year increase of 5.61%; the profit attributable to shareholders was HKD 47.361 million, a year-on-year increase of 295.37%; basic earnings per share were HKD 0.0442. The announcement stated that the profit attributable to shareholders was mainly due to (i) an increase in operating revenue from the medical segment; (ii) a decrease in non-cash fair value losses on investment properties; (iii) an increase in fair value gains on investments held for trading; which were partially offset by (iv) a decrease in net foreign exchange gains for the first half of 2025.